BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8384712)

  • 1. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes.
    Cristiano RJ; Smith LC; Woo SL
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2122-6. PubMed ID: 8384712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex.
    Cristiano RJ; Smith LC; Kay MA; Brinkley BR; Woo SL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11548-52. PubMed ID: 8265587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer.
    Nagasaki Y; Matsubara Y; Takano H; Fujii K; Senoo M; Akanuma J; Takahashi K; Kure S; Hara M; Kanegae Y; Saito I; Narisawa K
    Pediatr Res; 1999 Apr; 45(4 Pt 1):465-73. PubMed ID: 10203136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer.
    Fisher KJ; Wilson JM
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):49-58. PubMed ID: 8166659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer.
    Fang B; Eisensmith RC; Li XH; Finegold MJ; Shedlovsky A; Dove W; Woo SL
    Gene Ther; 1994 Jul; 1(4):247-54. PubMed ID: 7584088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of DNA using YEE(GalNAcAH)3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor.
    Merwin JR; Noell GS; Thomas WL; Chiou HC; DeRome ME; McKee TD; Spitalny GL; Findeis MA
    Bioconjug Chem; 1994; 5(6):612-20. PubMed ID: 7873664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocytes from wild-type or heterozygous donors are equally effective in achieving successful therapeutic liver repopulation in murine phenylketonuria (PKU).
    Hamman KJ; Winn SR; Harding CO
    Mol Genet Metab; 2011 Nov; 104(3):235-40. PubMed ID: 21917493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.
    Harding CO; Gillingham MB; Hamman K; Clark H; Goebel-Daghighi E; Bird A; Koeberl DD
    Gene Ther; 2006 Mar; 13(5):457-62. PubMed ID: 16319949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes.
    Singh M; Ariatti M
    J Control Release; 2003 Oct; 92(3):383-94. PubMed ID: 14568419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic basis of sexual dimorphism in PKU mice after genome-targeted PAH gene therapy.
    Chen L; Thung SN; Woo SL
    Mol Ther; 2007 Jun; 15(6):1079-85. PubMed ID: 17406346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient mice.
    Liu TJ; Kay MA; Darlington GJ; Woo SL
    Somat Cell Mol Genet; 1992 Jan; 18(1):89-96. PubMed ID: 1312261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility on systemic delivery of asialoorosomucoid complex to hepatic origin cells mediated by asialoglycoprotein receptor.
    Jun S; Xia J; Wang Y; Wang Y; Yiqiang Z; Shen Q
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):234-5, 239. PubMed ID: 16201257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis and binding of asialoorosomucoid by hepatocytes from rats with jejunoileal bypass.
    Serbource-Goguel/Seta N; Borel B; Dodeur M; Scarmato P; Bourel B; Feger J; Durand G
    Hepatology; 1985; 5(2):220-3. PubMed ID: 3979953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asialoglycoprotein receptor in human isolated hepatocytes from normal liver and its apparent increase in liver with histological alterations.
    Eisenberg C; Seta N; Appel M; Feldmann G; Durand G; Feger J
    J Hepatol; 1991 Nov; 13(3):305-9. PubMed ID: 1808223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for phenylketonuria.
    Eisensmith RC; Woo SL
    Acta Paediatr Suppl; 1994 Dec; 407():124-9. PubMed ID: 7766948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
    Wu GY; Wu CH
    J Biol Chem; 1987 Apr; 262(10):4429-32. PubMed ID: 3558345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of DNA for gene therapy via receptors.
    Findeis MA; Merwin JR; Spitalny GL; Chiou HC
    Trends Biotechnol; 1993 May; 11(5):202-5. PubMed ID: 7763812
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered role of microtubules in asialoglycoprotein trafficking in developing liver.
    Kaufman SS; Blain PL; Park JH; Tuma DJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G129-37. PubMed ID: 2301574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent.
    Cho CW; Cho YS; Lee HK; Yeom YI; Park SN; Yoon DY
    Biotechnol Appl Biochem; 2000 Aug; 32(1):21-6. PubMed ID: 10918034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated gene delivery and expression in vivo.
    Wu GY; Wu CH
    J Biol Chem; 1988 Oct; 263(29):14621-4. PubMed ID: 3049582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.